Viewing Study NCT00217568

Home

Certify Doc

Genes

Clinical Trials

CompTox

DrugMatrix

Open Targets

Products

Support

Bugs

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-24 @ 5:43 PM

Ignite Modification Date: 2026-03-06 @ 6:23 PM

Study NCT ID: NCT00217568

Status: COMPLETED

Last Update Posted: 2010-09-21

First Post: 2005-09-20

Is Gene Therapy: True

Has Adverse Events: False

Brief Title: Docetaxel and Carboplatin in Treating Patients With Relapsed Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cavity Cancer

Sponsor: Fred Hutchinson Cancer Center

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module